CML patients with better outcomes could have done better due to genetic factors, such as AA alleles (homozygosis at KIR3DL1) and HLA-Bw4 associated with educated and highly cytotoxic NK cells able to detect malignant cells. Here, KIR3DL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.